Mirabel Forteh
Nurse Practitioner · Stillwater, OKNPI 1679015416
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,969 of the $6,712 with a category attached, or 88.9%. It is spread thinly across 28 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,999 and has fallen 76.3% since, to $474 in 2025. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Medtronic$990
- Johnson & Johnson$785
- Abbott$546
- Merck$544
- Boehringer Ingelheim$397
- plus $2K from 22 others
What the payments were for
- Travel & lodging$74311%
- Food & beverage$5,96989%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 79 | $1,284 |
| Medtronic | 11 | $990 |
| Johnson & Johnson | 43 | $785 |
| Abbott | 29 | $546 |
| Merck | 39 | $544 |
| Boehringer Ingelheim | 22 | $397 |
| Pfizer | 19 | $289 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $274 |
| E.r. Squibb & Sons, L.L.C. | 17 | $251 |
| AstraZeneca | 13 | $212 |
| Amarin Pharma, Inc. | 11 | $168 |
| Kestra Medical Technology Services, Inc. | 8 | $162 |
| Lexicon Pharmaceuticals, Inc. | 8 | $138 |
| Sanofi-aventis U.S. LLC | 6 | $109 |
| Novo Nordisk | 7 | $107 |
| Amgen | 4 | $74 |
| Bayer | 4 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| Boston Scientific | 2 | $50 |
| Edwards Lifesciences | 2 | $49 |
| Esperion Therapeutics, Inc. | 3 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $27 |
| Surmodics, Inc. | 2 | $21 |
| Atricure, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,712 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 22 | $12,515 |
| XareltoRivaroxaban | 11 | $9,444 |
| EntrestoSacubitril/Valsartan | 13 | $7,601 |
| BrilintaTicagrelor | 16 | $6,919 |
| EliquisApixaban | 11 | $6,099 |
| ClopidogrelClopidogrel Bisulfate | 55 | $699 |
| Prasugrel Hcl | 15 | $640 |
| Atorvastatin Calcium | 39 | $354 |
| Rosuvastatin Calcium | 36 | $308 |
| Metoprolol Succinate | 58 | $306 |
| Lisinopril | 27 | $99 |
| Spironolactone | 21 | $98 |
| Losartan Potassium | 28 | $94 |
| Carvedilol | 19 | $90 |
| Furosemide | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Brilinta | $212 | $19,43438 claims |
| Johnson & JohnsonXarelto | $785 | $9,44411 claims |
| NovartisEntresto | $1,284 | $7,60113 claims |
| PfizerEliquis | $289 | $6,09911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Other nurse practitioner in Stillwater
- Ashley WardStillwater$9K
- Jenny GuthrieTulsa$106K
- Leah MeltonNorman$87K
- Sara GoreOklahoma City$52K
- Teisha GalleglyMoore$43K
- Stacy NewberryTulsa$28K
- Russell RoomsOklahoma City$24K
- Grant YoungOklahoma City$15K
- Monica LawsonNorman$15K
- Amanda SmallTulsa$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.